NEW YORK (GenomeWeb News) – Epistem said today that Becton Dickinson will distribute the firm's Mycobacterium tuberculosis test on a global basis, excluding India and the Indian Sub-Continent.

The molecular test, which recently received the CE-IVD Mark, runs on Epistem's Genedrive platform.

Manchester, UK-based Epistem said that it will receive an upfront payment of $1 million and further milestone payments up to $3 million. In addition, the agreement includes escalating supply volumes over the next five years.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.